To better characterize the mechanics of the metabolic adaptation driven by PML::RARα, we analyzed the mRNA and protein levels of key metabolic enzymes in primary blasts from APL and AML patients and in PR9/MT cells treated with ZnSO4 for 6 h. The gene discussed is RARA; the disease is acute promyelocytic leukemia.